State of the Art Symposium

SA 1 - Artificial intelligence (AI) in clinical practice: life past the hype

Lectures

1
Chairperson's introduction

Chairperson's introduction

05:00Merel Huisman, Nijmegen / NL

2
Clinical AI products in body imaging: an overview

Clinical AI products in body imaging: an overview

15:00Renato Cuocolo, Naples / IT

3
EU Artificial Intelligence Act: impact on medical imaging

EU Artificial Intelligence Act: impact on medical imaging

15:00Hugh Harvey, Banstead / UK

4
Raising the bar: clinical trials for healthcare AI products

Raising the bar: clinical trials for healthcare AI products

15:00Ritse Mann, Nijmegen / NL

5
Post-market surveillance for artificial intelligence

Post-market surveillance for artificial intelligence

15:00Stephan Romeijn, Utrecht / NL

6
Panel discussion: The AI act: friend or foe?

Panel discussion: The AI act: friend or foe?

25:00Panel discussion: The AI act: friend or foe?

5 min
Chairperson's introduction
Merel Huisman, Nijmegen / Netherlands
15 min
Clinical AI products in body imaging: an overview
Renato Cuocolo, Naples / Italy
  1. To discuss some of the more common clinical applications of AI in body imaging.
  2. To analyse limitations emerging from the clinical implementation of AI software.
  3. To consider potential strategies to improve the clinical impact of AI in body imaging.
15 min
EU Artificial Intelligence Act: impact on medical imaging
Hugh Harvey, Banstead / United Kingdom
  1. To learn about the specific regulations within the EU Artificial Intelligence Act that pertain to medical imaging applications.
  2. To appreciate the ethical considerations and patient safety measures introduced by the Act.
  3. To understand the broader impacts of the Act on innovation, research, and clinical practice within the field of medical imaging across Europe.
15 min
Raising the bar: clinical trials for healthcare AI products
Ritse Mann, Nijmegen / Netherlands
  1. To understand the types of studies common in AI imaging tools.
  2. To be able to define the value of research results for AI in imaging in a clinical context.
  3. To discuss minimal validation standards before and during the implementation of AI in imaging.
15 min
Post-market surveillance for artificial intelligence
Stephan Romeijn, Utrecht / Netherlands
  1. To recognise the importance of post-market surveillance for AI in radiology, ensuring ongoing safety and effectiveness.
  2. To identify challenges in post-market surveillance, focusing on data integrity and adherence to regulations.
  3. To explore methodologies for effective surveillance, such as generating real-world evidence and implementing proactive risk management strategies.
25 min
Panel discussion: The AI act: friend or foe?

This session offers AI-generated subtitles.